1 in 6
Couples Face Infertility in India
2.5M+
IVF Cycles Performed Annually in India
50M+
Women With PCOS in India
WHO-GMP
Certified Manufacturing
Women’s health in India is at an inflection point. Infertility rates are rising. Endometriosis remains chronically underdiagnosed. PCOS affects an estimated 1 in 5 women of reproductive age. And IVF — once considered a last resort — is now a mainstream clinical pathway sought by hundreds of thousands of couples every year.
This growing clinical demand requires a pharmaceutical partner that understands women’s health at the depth a specialist does — not just a company that lists gynaecology products in a catalogue. It requires WHO-GMP certified manufacturing, formulation expertise across hormonal therapy, fertility support, progesterone supplementation and nutritional management, and the kind of scientific credibility that gives a prescribing gynaecologist or IVF specialist the confidence to recommend a brand by name.
Quinek Life Sciences is built for exactly this clinical environment. This article explains who we are, what our gynaecology and IVF portfolio covers, and why doctors and distributors across India trust Quinek as their specialty pharma partner in women’s health.
IN THIS ARTICLE
- The Gynaecology & IVF Pharma Landscape in India
- Why Quality Certification Is Non-Negotiable in Women’s Health
- Progesterone & Hormonal Support — Core of the Portfolio
- IVF & Fertility Range — Complete Cycle Support
- Gynaecology Range — Full Women’s Health Portfolio
- Why Gynaecologists & IVF Specialists Choose Quinek
- Why Distributors & Stockists Choose Quinek
- Partner With Quinek Life Sciences
The Gynaecology & IVF Pharma Landscape in India
India is among the largest markets for gynaecology and fertility pharmaceuticals in Asia — and one of the fastest growing. The convergence of rising infertility rates, increasing awareness of reproductive health, expanding IVF infrastructure beyond metro cities and a growing middle-class willingness to invest in fertility treatment has created significant and sustained demand for quality gynae and IVF pharmaceutical products.
Yet the market is crowded — and unevenly certified. Many companies offer gynaecology products without the manufacturing standards, formulation depth or clinical credibility that specialty prescribers require. For a gynaecologist or IVF specialist recommending a progesterone formulation or an FSH injection, the quality of what reaches the patient matters enormously.
INDIA WOMEN’S HEALTH — KEY DATA
Infertility affects approximately 10–15% of couples in India · Source: NCBI — Infertility in India
PCOS prevalence in Indian women of reproductive age: 9–22% · Source: NCBI — PCOS in India
India has over 1,400 IVF centres — among the highest globally · Source: WHO Infertility Report, 2023
Why Quality Certification Is Non-Negotiable in Women’s Health
Gynaecology and IVF pharmaceuticals are not ordinary medicines. Many are administered to pregnant women, women undergoing hormonal stimulation, or patients in the critical window of embryo implantation. The stakes of formulation inconsistency are not abstract — they are measured in failed cycles, early pregnancy losses and missed clinical windows.
Hormonal Precision
FSH, HMG and HCG formulations must deliver exact IU dosing. Variability in potency directly affects follicular response and cycle outcomes.
Progesterone Bioavailability
SR and vaginal progesterone formulations must release consistently. Inconsistent dissolution profiles cause breakthrough symptoms and threatened miscarriage.
Sterility of Injectables
Injectable gonadotropins and HCG must be manufactured under sterile conditions. Non-GMP injectables carry infection and contamination risk.
Patient Population Safety
Pregnant women and women undergoing IVF are among the most pharmacologically vulnerable patients. GMP certification is the minimum acceptable standard.
Progesterone & Hormonal Support — Core of the Portfolio
Progesterone supplementation is the single most prescribed intervention in both IVF cycles and early pregnancy management. From luteal phase support after egg retrieval to threatened miscarriage management in spontaneous conceptions, progesterone is indispensable — and the formulation choice matters.
IVF & Fertility Range — Complete Cycle Support
Our IVF and fertility portfolio covers every phase of the assisted reproduction cycle — from ovarian stimulation and follicle development to trigger injection, endometrial preparation, luteal phase support and post-retrieval care. IVF specialists can manage the full protocol with Quinek formulations — without having to source from multiple suppliers.
IVF CYCLE PHASE — QUINEK FORMULATION MAPPING
Ovarian Stimulation
GY-Fish 75 / 150 (FSH)
Gynotrop 75 / 150 (HMG)
Trigger Injection
GY-NRH 5000
(HCG 5000 IU)
Endometrial Prep
Estrafleg Gel / Oral
AL-GRO Cream
Luteal Support
Momtime Gel · QGESS-200
Ezi-Trone INJ
Post-Retrieval Care
GYPROST 125 / 250
(Carboprost)
Gynaecology Range — Full Women’s Health Portfolio
Beyond IVF, our gynaecology portfolio addresses the full breadth of clinical needs a practising gynaecologist encounters — PCOS management, ovulation induction, endometriosis, hormonal contraception, vaginal infection, menstrual disorders, nutritional deficiencies in pregnancy and antifungal care.
Why Gynaecologists & IVF Specialists Choose Quinek
Why Distributors & Stockists Choose Quinek
The gynaecology and IVF pharma segment offers strong commercial opportunity — but only with the right certified partner. Distributors and C&F agents partnering with Quinek gain access to a portfolio that doctors ask for by name, backed by certifications that protect against regulatory exposure and quality incidents that can damage territory relationships built over years.
FOR DISTRIBUTION PARTNERS
Certified portfolio — WHO-GMP · GLP · ISO · DCGI · FSSAI across all products
Specialty focus — gynaecology and IVF are high-value, high-frequency prescription segments
Transparent terms — clear territory agreements, credit terms and marketing support
Supply reliability — consistent availability backed by compliant manufacturing capacity
Brand credibility — prescribers trust certified brands, making territory development faster
“Women’s health deserves pharmaceutical precision. Every formulation. Every cycle. Every patient.”
Quinek Life Sciences — WHO-GMP Certified Gynaecology & IVF Pharma Company, India
References & Further Reading
- WHO — 1 in 6 People Globally Affected by Infertility, 2023
- NCBI — Infertility Burden in India
- NCBI — PCOS Prevalence in Indian Women
- WHO — Good Manufacturing Practices for Pharmaceuticals
- Quinek Life Sciences — Gynaecology Segment
- Quinek Life Sciences — IVF & Fertility Segment
- Quinek Life Sciences — Quality Certifications
This article is for educational and informational purposes. All products mentioned are prescription medicines for professional use only. Quinek Life Sciences holds valid WHO-GMP, GLP, ISO, DCGI and FSSAI certifications at the time of publication.